Oxford-AstraZeneca Vaccine Designer to Sell Shares in U.S. IPO
(Bloomberg) -- A company founded by University of Oxford scientists who designed the vaccine co-developed with AstraZeneca Plc will begin selling American depositary shares in the U.S., according to a filing.
Vaccitech Plc, founded by Oxford professors Adrian Hill and Sarah Gilbert, wants to raise as much as $100 million by selling shares to investors, according to the filing Friday. In addition to vaccines against infectious disease, the company is aiming to develop treatments for hepatitis B virus, human papillomavirus and prostate cancer.
The rush to develop shots that prevent Covid-19 has put the Oxford scientists, along with vaccine developers around the world, in the spotlight. Their vaccine has been seen as a key to halting the pandemic around the world because of its low price, and because of ease of storage at refrigerator temperatures.
However, even as Vaccitech seeks to sell shares in the U.S., the vaccine hasn't yet been submitted for emergency clearance there, and three other companies have already gained authorization for competing inoculations. The Oxford-AstraZeneca vaccine has suffered other setbacks in markets where it has been cleared for use.
Health officials are looking closely at the vaccine since it's been associated with a rare form of blood clotting that may occur when the immune system attacks targets the body's blood platelets.
The filing noted that Oxford agreed to forgo its share of royalties until after the pandemic period and as a result, “we do not expect to receive any share of net sales of the vaccine until after the pandemic is over, as determined in good faith by AstraZeneca, and in any event no earlier than July 1, 2021.”
Underwriters of the offering include Morgan Stanley & Co., Jeffries LLC, Barclays Capital Inc., William Blair & Co., and H.C. Wainwright & Co.
©2021 Bloomberg L.P.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.